Literature DB >> 15742170

Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.

Antoine de Mascarel1, Agnès Ruskone-Fourmestraux, Anne Lavergne-Slove, Francis Megraud, Pierre Dubus, Jean-Philippe Merlio.   

Abstract

The persistence of gastric lymphoma after Helicobacter pylori eradication may be difficult to evidence on endoscopic and histological examination. The aims of the study were to evaluate the detection of monoclonal immunoglobulin H (IgH) gene rearrangement in endoscopically infiltrated and normal mucosa at diagnosis and during follow-up in order to determine its clinical and prognostic impact. We studied 60 gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT), and IgH monoclonality was detected at diagnosis in 52 patients (87%). The endoscopically normal mucosa contained clonal lymphomatous cells in 69% of cases before remission. A complete histological remission (HR) was observed in 28 patients (47%). Among them, 23 were followed for molecular remission (MR). The median delay was 10 months to achieve HR and 18 months to achieve MR. Interestingly, patients with HR but not MR had a longer delay to achieve HR (21 months) (P=0.0006) and a more frequent clonal normal mucosa at diagnosis (88%) than patients with both HR and MR (10 months and 39%, respectively). The presence of monoclonal B cells at both infiltrated and normal sites may therefore identify patients with a longer delay to achieve complete response, suggesting that molecular dissemination may require therapeutic intensification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742170     DOI: 10.1007/s00428-005-1217-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Clonal evolution of gastric lymphoma of mucosa-associated lymphoid tissue type.

Authors:  A Yamauchi; Y Tomita; H Miwa; H Sakamoto; H Sugiyama; K Aozasa
Journal:  Mod Pathol       Date:  2001-10       Impact factor: 7.842

2.  Relapse of low-grade gastric MALT lymphoma after Helicobacter pylori eradication: true relapse or persistence? Long-term post-treatment follow-up of a multicenter trial in the north-east of Italy and evaluation of the diagnostic protocol's adequacy.

Authors:  A Savio; G Zamboni; P Capelli; R Negrini; G Santandrea; A Scarpa; A Fuini; F Pasini; A Ambrosetti; A Paterlini; F Buffoli; G P Angelini; P Cesari; F Rolfi; M Graffeo; A Pascarella; M Valli; A Mombello; A Ederle; G Franzin
Journal:  Recent Results Cancer Res       Date:  2000

3.  Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.

Authors:  C Montalban; A Santon; D Boixeda; C Redondo; I Alvarez; J L Calleja; C M de Argila; C Bellas
Journal:  Haematologica       Date:  2001-06       Impact factor: 9.941

4.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.

Authors:  A C Wotherspoon; C Ortiz-Hidalgo; M R Falzon; P G Isaacson
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

5.  [Clinical staging classification of non-Hodgkin's lymphomas (author's transl)].

Authors:  K Musshoff
Journal:  Strahlentherapie       Date:  1977-04

6.  Healing gastric MALT lymphomas by eradicating H pylori?

Authors:  M Stolte; S Eidt
Journal:  Lancet       Date:  1993-09-04       Impact factor: 79.321

7.  Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group.

Authors:  W Fischbach; B Dragosics; M E Kolve-Goebeler; C Ohmann; A Greiner; Q Yang; S Böhm; P Verreet; O Horstmann; M Busch; E Dühmke; H K Müller-Hermelink; K Wilms; S Allinger; P Bauer; S Bauer; A Bender; G Brandstätter; A Chott; C Dittrich; K Erhart; D Eysselt; H Ellersdorfer; A Ferlitsch; M A Fridrik; A Gartner; M Hausmaninger; W Hinterberger; K Hügel; P Ilsinger; K Jonaus; G Judmaier; J Karner; E Kerstan; P Knoflach; K Lenz; A Kandutsch; M Lobmeyer; H Michlmeier; H Mach; C Marosi; W Ohlinger; H Oprean; H Pointer; J Pont; H Salabon; H J Samec; A Ulsperger; A Wimmer; F Wewalka
Journal:  Gastroenterology       Date:  2000-11       Impact factor: 22.682

8.  Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa.

Authors:  M Q Du; T C Diss; A Dogan; H T Ye; A Aiello; A C Wotherspoon; L X Pan; P G Isaacson
Journal:  J Pathol       Date:  2000-12       Impact factor: 7.996

9.  Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both?

Authors:  A Savio; G Franzin; A C Wotherspoon; G Zamboni; R Negrini; F Buffoli; T C Diss; L Pan; P G Isaacson
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113

10.  Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

Authors:  E Bayerdörffer; A Neubauer; B Rudolph; C Thiede; N Lehn; S Eidt; M Stolte
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

View more
  5 in total

1.  Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis.

Authors:  Hidekazu Suzuki; Yoshimasa Saito; Toshifumi Hibi
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

Review 2.  Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.

Authors:  Chris M Bacon; Ming-Qing Du; Ahmet Dogan
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

Review 3.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

Review 4.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

Review 5.  Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis.

Authors:  Angelo Zullo; Cesare Hassan; Alessandro Andriani; Francesca Cristofari; Chiara Bassanelli; Gian Paolo Spinelli; Silverio Tomao; Sergio Morini
Journal:  Med Oncol       Date:  2009-03-24       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.